Relative bioavailability of oral low dose methotrexate. A comparison of 2 different formulations. 1988

S D Fosså, and K Tveit, and O Börmer, and A Moxnes, and N P Jørgensen, and H Orjaseter, and D T Kristoffersen
Department of Medical Oncology and Radiotherapy, Norwegian Radium Hospital, Oslo.

In 39 patients the bioavailability of methotrexate from the two tablets Emthexat 2.5 mg and Methotrexate 2.5 mg was assessed in a double-blind study after a single oral dose of 30 mg/m2 Methotrexate. There was a considerable inter-individual variation of the serum pharmacokinetics in regard to Cmax and tmax, independent on the MTX formulation. Emthexat 2.5 mg tablets and Methotrexate 2.5 mg tablets were bioequivalent according to the definition (AUCE greater than or equal to AUCM X 80%).

UI MeSH Term Description Entries
D008297 Male Males
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities
D013607 Tablets Solid dosage forms, of varying weight, size, and shape, which may be molded or compressed, and which contain a medicinal substance in pure or diluted form. (Dorland, 28th ed) Tablet

Related Publications

S D Fosså, and K Tveit, and O Börmer, and A Moxnes, and N P Jørgensen, and H Orjaseter, and D T Kristoffersen
November 1993, The Journal of rheumatology,
S D Fosså, and K Tveit, and O Börmer, and A Moxnes, and N P Jørgensen, and H Orjaseter, and D T Kristoffersen
December 1995, International journal of clinical pharmacology and therapeutics,
S D Fosså, and K Tveit, and O Börmer, and A Moxnes, and N P Jørgensen, and H Orjaseter, and D T Kristoffersen
January 2001, European journal of drug metabolism and pharmacokinetics,
S D Fosså, and K Tveit, and O Börmer, and A Moxnes, and N P Jørgensen, and H Orjaseter, and D T Kristoffersen
August 2019, Clinical pharmacology in drug development,
S D Fosså, and K Tveit, and O Börmer, and A Moxnes, and N P Jørgensen, and H Orjaseter, and D T Kristoffersen
January 2009, Alternative therapies in health and medicine,
S D Fosså, and K Tveit, and O Börmer, and A Moxnes, and N P Jørgensen, and H Orjaseter, and D T Kristoffersen
May 2012, Journal of Zhejiang University. Science. B,
S D Fosså, and K Tveit, and O Börmer, and A Moxnes, and N P Jørgensen, and H Orjaseter, and D T Kristoffersen
February 2013, BMC veterinary research,
S D Fosså, and K Tveit, and O Börmer, and A Moxnes, and N P Jørgensen, and H Orjaseter, and D T Kristoffersen
August 2019, AAPS PharmSciTech,
S D Fosså, and K Tveit, and O Börmer, and A Moxnes, and N P Jørgensen, and H Orjaseter, and D T Kristoffersen
November 2010, Clinical therapeutics,
S D Fosså, and K Tveit, and O Börmer, and A Moxnes, and N P Jørgensen, and H Orjaseter, and D T Kristoffersen
April 2018, European journal of nutrition,
Copied contents to your clipboard!